AzTrials
AzTrials

StrokeEarly Phase 1NCT04829071

Cognition and Motor Learning Post-stroke

A Early Phase 1 study testing Explicit motor learning and Implicit motor learning in people with Stroke and CVA (Cerebrovascular Accident), run by University of Southern California at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project seeks to determine how post-stroke cognitive impairment moderates motor learning during walking in older adults with chronic stroke and identify brain structural markers that mediate this relationship. Read more about this study

Who is it for?
Ages 45 to 85 years
Conditions the study is for
Stroke, CVA (Cerebrovascular Accident)
What is being tested?
Explicit motor learning and Implicit motor learning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
65 participants
Where
1 siteUnited States
Study dates
16 Jan 2023to 14 Dec 2026
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral stroke
  • Stroke occurred more than 6 months prior
  • Paresis confined to one side
  • Independently ambulatory (including the use of assistive devices)
  • Able to walk for 5 minutes without stopping
  • Answers no to all general health questions on the PAR-Q+
  • Willingness to complete study procedures

Who cannot join

  • Brainstem or cerebellar stroke
  • Aphasia (expressive, receptive, or global)
  • Any major musculoskeletal or non-stroke neurological condition that interferes with the assessment of sensorimotor or cognitive function
  • Metal in the head (except in the mouth), implanted cranial or thoracic devices that violate MRI safety regulations
  • Uncontrolled hypertension (>160/110mmHg)
  • Concurrent physical therapy
Show all 9Show fewer
  • Claustrophobia
  • Significant cognitive deficit or dementia (<20 on MoCA)
  • Inability to give informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristan Leech, PT, DPT, PhD contact

(323) 442-1583

kleech@pt.usc.edu

Sarah Kettlety, MS contact

(323) 442-1196

kettlety@usc.edu

United States1 site, 1 recruiting
  • Center for Health Professions

    Los Angeles, California, 90033

    Kristan Leech, PT, DPT, PhD, 3124421583

    Recruiting

Other trials in United States

About this study

Official title: Cognition as a Moderator of Motor Learning Post-stroke

This project seeks to determine how post-stroke cognitive impairment moderates motor learning during walking in older adults with chronic stroke and identify brain structural markers that mediate this relationship. The chosen experimental design integrates biomechanical analyses, neuropsychological assessments, and brain imaging techniques to determine the impact of post-stroke cognitive impairment severity on two forms of motor learning (explicit and implicit) and examine the role of the dorsolateral prefrontal cortex in the relationship between cognition and explicit motor learning. Ultimately, this work may lead to the development of a more comprehensive, effective treatment approach to improve walking dysfunction in older adults post-stroke.

Being tested
Explicit motor learning, Implicit motor learning
Keywords
stroke, walking, rehabilitation, cognition
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Explicit motor learningBehavioural

    Participants will be provided with visual feedback of their right and left step lengths on a screen in front of a treadmill.

  • Implicit motor learningBehavioural

    Participants will walk on a treadmill that drives their right and left legs to move at two different speeds.

Study groups in NCT04829071
Study groupRoleWhat they receive
Evaluating motor learning and brain structures post-strokeExperimentalWe will use a single arm design to determine the impact of post-stroke cognitive impairment on two forms of motor learning (implicit and explicit) and evaluate the structural integrity of relevant brain structures in 65 individuals post stroke
Receives: Behavioral: Explicit motor learning; Behavioral: Implicit motor learning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. step length asymmetry - change in performance

    characterized as a comparison between the right and left step lengths; captured to quantify change in performance with biofeedback or split belt walking

    Measured: Measured at three timepoints of interest within each testing session: baseline and at the beginning and end of the interventions; participants will complete 2 testing sessions over approximately 1 months

Secondary outcomes (1)
  1. step length asymmetry - immediate retention

    characterized as a comparison between the right and left step lengths; captured to quantify the retention of a newly learned walking pattern

    Measured: Measured after motor learning in each testing session; participants will complete 2 testing sessions over approximately 1 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2021
  2. Study start16 Jan 2023
  3. Primary completion14 Aug 2026 (estimated)
  4. Study completion14 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
65 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04829071
Sponsor's protocol ID
APP-21-00898
Status last verified
Oct 2025
First submitted
30 Mar 2021
Last updated
4 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All de-identified data from our research that underlie results in a publication will be made available on the Open Science Framework.

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Explicit motor learning and Implicit motor learning in people with Stroke and CVA (Cerebrovascular Accident), run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kristan Leech, PT, DPT, PhD ((323) 442-1583, kleech@pt.usc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

step length asymmetry - change in performance (time frame: Measured at three timepoints of interest within each testing session: baseline and at the beginning and end of the interventions; participants will complete 2 testing sessions over approximately 1 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in